Bonesupport
323.2
SEK
+2.34 %
Less than 1K followers
BONEX
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
+2.34%
-8.96%
-16.44%
-6.59%
+7.23%
+47.58%
+696.06%
+1,075.27%
+910%
Bonesupport operates in the medical technology industry and focuses on the development and manufacture of bioceramic implants for bone repair and reconstruction. The company's products are aimed at surgeons and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. Bonesupport was founded in 1999 and is headquartered in Lund, Sweden.
Read moreMarket cap
21.58B SEK
Turnover
9.45M SEK
Revenue
898.73M
EBIT %
18.49 %
P/E
158.43
Dividend yield-%
-
Financial calendar
24.4
2025
Interim report Q1'25
27.5
2025
General meeting '25
15.7
2025
Interim report Q2'25
ShowingAll content types

Bonesupport, Audiocast with teleconference, Year end report, 2024
BONESUPPORT HOLDING AB (publ) – publishes year end report 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Modular Finance IR Consensus: BONESUPPORT – Consensus estimates Q4 2024
BONESUPPORT HOLDING AB (publ) – Invitation to Conference Call and Webcast for Year-End Report 2024
CERAMENT® G AND CERAMENT® V contributes to improved survival rates
Change in BONESUPPORT’s Nomination Committee ahead of the 2025 Annual General Meeting following a change in ownership
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
Announced Insider Trading
Announced Insider Trading
Redeye: BONESUPPORT Q3 - Surprising on US sales and EBIT
